Search Results - "Kovitz, Craig"

S2700 Fecal Microbiota Transplantation as First-Line Treatment for Immune-Mediated Colitis by Wang, Yinghong, Varatharajalu, Krishnavathana, Shatila, Malek, Campbell, Mathew T., Kovitz, Craig A., Msaouel, Pavlos

Get full text

Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia by Kovitz, Craig, Kantarjian, Hagop, Garcia-Manero, Guillermo, Abruzzo, Lynne V., Cortes, Jorge

“…During therapy with imatinib, some patients with chronic myeloid leukemia (CML) develop chromosomal abnormalities in Philadelphia chromosome (Ph)-negative…”
Get full text

Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy by Jain, Tania, Bar, Merav, Kansagra, Ankit J., Chong, Elise A., Hashmi, Shahrukh K., Neelapu, Sattva S., Byrne, Michael, Jacoby, Elad, Lazaryan, Aleksandr, Jacobson, Caron A., Ansell, Stephen M., Awan, Farrukh T., Burns, Linda, Bachanova, Veronika, Bollard, Catherine M., Carpenter, Paul A., DiPersio, John F., Hamadani, Mehdi, Heslop, Helen E., Hill, Joshua A., Komanduri, Krishna V., Kovitz, Craig A., Lazarus, Hillard M., Serrette, Justin M., Mohty, Mohamad, Miklos, David, Nagler, Arnon, Pavletic, Steven Z., Savani, Bipin N., Schuster, Stephen J., Kharfan-Dabaja, Mohamed A., Perales, Miguel-Angel, Lin, Yi

“…Axicabtagene ciloleucel (YESCARTA; Kite Pharma, a Gilead Company, Los Angeles CA) and tisagenlecleucel (KYMRIAH; Novartis Pharmaceuticals Corp., Basel,…”
Get full text

Erratum to “Periorbital edema associated with alpelisib” [Cancer Treatment and Research Communications 32 (2022) 100596] by Dao, Elizabeth A., George, Saira J., Heberton, Meghan M., Pacha, Omar, Kovitz, Craig A., Patel, Anisha B., Phillips, Rhea M.

Get full text

Periorbital edema associated with alpelisib by Dao, Elizabeth A., George, Saira J., Heberton, Meghan M., Pacha, Omar, Kovitz, Craig A., Patel, Anisha B., Phillips, Rhea M.

“…•Alpelisib is associated with cutaneous adverse events including morbilliform or acneiform rash, as well as peripheral and periorbital…”
Get full text

Massive nodular melanoma: a case report by Harting, Mandy, Tarrant, William, Kovitz, Craig A, Rosen, Ted, Harting, Matthew T, Souchon, Eduardo

“…Melanoma is the sixth most common cancer in the United States, and its incidence rates are currently increasing faster than for any other cancer. Nodular…”
Get full text

First-line treatment of fecal microbiota transplantation for immune-mediated colitis by Wang, Yinghong, Varatharajalu, Krishnavathana, Shatila, Malek, Campbell, Matthew T, Msaouel, Pavlos, Kovitz, Craig A.

“…2510 Background: The management of moderate to severe immune-mediated colitis (IMC) includes immunosuppression with steroids and/or biologic agents. Long-term…”
Get full text

Outcomes of patients (pts) with advanced renal cell carcinoma (aRCC) treated with cabozantinib (CABO) after lenvatinib plus pembrolizumab (LEN+PEM) by Haro-Silerio, Jaime Ivan, Johns, Andrew, Moussa, Mohammad Jad, Wang, Mindy, Wang, Emily, Kovitz, Craig A., Campbell, Matthew T, Jonasch, Eric, Shah, Amishi Yogesh, Tannir, Nizar M.

“…433 Background: LEN+PEM is an approved first-line therapy for aRCC. In the CLEAR study, it produced a 71% objective response rate (ORR), an 18% complete…”
Get full text

S227 First-Line Treatment of Fecal Microbiota Transplantation for Immune-Mediated Colitis by Wang, Yinghong, Varatharajalu, Krishnavathana, Shatila, Malek, Thomas, Anusha, Campbell, Mathew, Msaouel, Pavlos, Kovitz, Craig, DuPont, Herbert

Get full text

A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases by Wang, Jianbo, Campbell, Matthew T, Shah, Amishi Yogesh, Goswami, Sangeeta, Msaouel, Pavlos, Alhalabi, Omar, Hahn, Andrew Warren, Kovitz, Craig A., Jana, Bagi RP, Araujo, John C., Gao, Jianjun, Zurita, Amado J., Jonasch, Eric, Corn, Paul Gettys, Tannir, Nizar M.

“…TPS745 Background: A SEER analysis from 2010 to 2013 demonstrated that the incidence of brain metastases(mets) at the diagnosis of renal cell carcinoma(RCC) is…”
Get full text

Characteristics and outcomes for patients (pts) with metastatic small cell urothelial carcinoma (mSCUC) by Wilson, Nathaniel R., Khandelwal, Jaanki, Xiao, Lianchun, Shah, Amishi Yogesh, Gao, Jianjun, Goswami, Sangeeta, Kovitz, Craig A., Guo, Charles, Czerniak, Bogdan, Logothetis, Christopher, Corn, Paul Gettys, Tannir, Nizar M., Siefker-Radtke, Arlene O., Alhalabi, Omar

“…522 Background: mSCUC is an aggressive cancer with historically poor outcomes. Methods: We performed a retrospective analysis of 216 pts with mSCUC treated at…”
Get full text

Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial by Tang, Chad, Sherry, Alexander D, Haymaker, Cara, Bathala, Tharakeswara, Liu, Suyu, Fellman, Bryan, Cohen, Lorenzo, Aparicio, Ana, Zurita, Amado J, Reuben, Alexandre, Marmonti, Enrica, Chun, Stephen G, Reddy, Jay P, Ghia, Amol, McGuire, Sean, Efstathiou, Eleni, Wang, Jennifer, Wang, Jianbo, Pilie, Patrick, Kovitz, Craig, Du, Weiliang, Simiele, Samantha J, Kumar, Rachit, Borghero, Yerko, Shi, Zheng, Chapin, Brian, Gomez, Daniel, Wistuba, Ignacio, Corn, Paul G

“…Despite evidence demonstrating an overall survival benefit with up-front hormone therapy in addition to established synergy between hormone therapy and…”
Get more information

Cerebral glucose transporter expression in HIV infection by KOVITZ, C. A, MORGELLO, S

“…Abnormalities in cerebral glucose metabolism have been demonstrated in patients with AIDS dementia complex (ADC), with increased consumption in early disease…”
Get full text

OCTS-06 A PHASE II STUDY OF NIVOLUMAB WITH IPILIMUMAB AND CABOZANTINIB IN PATIENTS WITH UNTREATED RENAL CELL CARCINOMA BRAIN METASTASES by Wang, Jianbo, Campbell, Matthew, Shah, Amishi Y, Goswami, Sangeeta, Msaouel, Pavlos, Alhalabi, Omar, Hahn, Andrew, Kovitz, Craig, Bagi, Jana, Araujo, John, Gao, Jianjun, Lin, John, Zurita, Amado, Jonasch, Eric, Corn, Paul, Tannir, Nizar

“…Abstract BACKGROUND The incidence of brain metastases(mets) at the diagnosis of renal cell carcinoma (RCC) is 1.51%, and around 12% of patients(pts) with…”
Get full text

Upper extremity deep venous thromboses at Keesler Medical Center: 1997-2000 by Strassburg, Amy D, Kovitz, Craig A

Get more information

Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract by Alhalabi, Omar, Wilson, Nathaniel, Xiao, Lianchun, Lin, Yiyun, Khandelwal, Jaanki, Moussa, Mohammad Jad, Msaouel, Pavlos, Navai, Neema, Gao, Jianjun, Kamat, Ashish M, Pilie, Patrick, Shah, Amishi Y, Goswami, Sangeeta, Matin, Surena, Kovitz, Craig, Holla, Vijaykumar, Guo, Charles, Czerniak, Bogdan, Logothetis, Christopher, Corn, Paul G, Dinney, Colin P N, Campbell, Matthew T, Hansel, Donna E, Tannir, Nizar M, Siefker-Radtke, Arlene O

“…Neoadjuvant chemotherapy (neoCTX) has been recommended as the optimal strategy in surgically resectable neuroendocrine carcinoma (NEC) of the urinary tract…”
Get full text

Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barrñ syndrome: a case report by Hughes, Caren L, Yorio, Jeffrey T, Kovitz, Craig, Oki, Yasuhiro

“…Introduction Guillain-Barre syndrome, or acute inflammatory demyelinating polyneuropathy, has been described in the presence of malignancies such as lymphoma…”
Get full text

Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report by Hughes, Caren L, Yorio, Jeffrey T, Kovitz, Craig, Oki, Yasuhiro

“…Guillain-Barre syndrome, or acute inflammatory demyelinating polyneuropathy, has been described in the presence of malignancies such as lymphoma…”
Get full text

Allogeneic bone marrow transplantatin at Wilford Hall U.S. Air Force Medical Center: 1987-1999 by Kovitz, Craig A

“…Wilford Hall Medical Center (WHMC), at Lackland Air Force Base in San Antonio, Texas, is the only center within the U.S. Department of Defense at which…”
Get full text

Secondary Leukemia after Imatinib Mesylate (IM) Therapy for Chronic Myelogenous Leukemia (CML) by Kovitz, Craig A., Kantarjian, Hagop M., Garcia-Manero, Guillermo, Abruzzo, Lynne V., Cortes, Jorge E.

“…Disease progression in CML is often marked by the acquisition of cytogenetic abnormalities beyond the Philadelphia chromosome (Ph), referred to as clonal…”
Get full text